We are live on ! Find out more
ANIP icon

ANI Pharmaceuticals
ANIP

157 hedge funds and large institutions have $379M invested in ANI Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 58 increasing their positions, 47 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more ownership

Funds ownership: 0% → 54% (+54%)

23% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 47

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5% less capital invested

Capital invested by funds: $399M → $379M (-$19.5M)

8% less funds holding

Funds holding: 170 → 157 (-13)

33% less call options, than puts

Call options by funds: $6.65M | Put options by funds: $9.9M

40% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 25

Holders
157
Holders Change
-13
Holders Change %
-7.65%
% of All Funds
3.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
58
Reduced
47
Closed
25
Calls
$6.65M
Puts
$9.9M
Net Calls
-$3.25M
Net Calls Change
-$3.46M

Top Buyers

1
PA
Perceptive Advisors
New York
+$15.6M
2
GT
Glenmede Trust
Pennsylvania
+$15.1M
3
BFA
BlackRock Fund Advisors
California
+$4.65M
4
Bank of America
Bank of America
North Carolina
+$4.12M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.66M

Top Sellers

1
CCM
Consonance Capital Management
New York
-$9.88M
2
CM
Castleark Management
Illinois
-$6.68M
3
SGAM
Smith Group Asset Management
Texas
-$3.96M
4
BIM
Bogle Investment Management
Massachusetts
-$3.7M
5
MCM
McKinley Capital Management
Alaska
-$3.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
76
Piermont Capital Management
Missouri
$439K -$8.56K -140 -2%
UBS Group
77
UBS Group
Switzerland
$418K -$757K -12,388 -64%
VFA
78
Virtus Fund Advisers
Connecticut
$411K – – –
Nisa Investment Advisors
79
Nisa Investment Advisors
Missouri
$376K +$183K +3,000 +94%
State of Tennessee, Department of Treasury
80
State of Tennessee, Department of Treasury
Tennessee
$366K – – –
TPSF
81
Texas Permanent School Fund
Texas
$353K -$13.7K -224 -4%
AIG
82
American International Group
New York
$353K -$4.77K -78 -1%
MLICM
83
Metropolitan Life Insurance Company (MetLife)
New York
$351K – – –
Wolverine Trading
84
Wolverine Trading
Illinois
$345K +$348K +5,694 New
Public Sector Pension Investment Board (PSP Investments)
85
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$343K – – –
Manulife (Manufacturers Life Insurance)
86
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$342K +$428 +7 +0.1%
RJA
87
Raymond James & Associates
Florida
$320K +$17.1K +280 +6%
NFA
88
Nationwide Fund Advisors
Ohio
$295K -$13.9K -227 -4%
Commonwealth Equity Services
89
Commonwealth Equity Services
Massachusetts
$283K -$11K -180 -4%
LPL Financial
90
LPL Financial
California
$281K – – –
Tudor Investment Corp
91
Tudor Investment Corp
Connecticut
$279K -$116K -1,900 -29%
CG
92
Cutler Group
California
$278K +$55K +900 +24%
CG
93
Caprock Group
Idaho
$261K -$6.05K -99 -2%
Thrivent Financial for Lutherans
94
Thrivent Financial for Lutherans
Minnesota
$261K +$14.7K +240 +6%
VCM
95
Violich Capital Management
California
$255K +$7.34K +120 +3%
AQR Capital Management
96
AQR Capital Management
Connecticut
$252K +$254K +4,152 New
GAM
97
Gotham Asset Management
New York
$251K -$38.3K -626 -13%
BA
98
BlackRock Advisors
Delaware
$249K -$4.95K -81 -2%
ASRS
99
Arizona State Retirement System
Arizona
$249K – – –
Squarepoint
100
Squarepoint
New York
$248K +$11.3K +184 +5%
2 3
4
5 6

ANIP Hedge Fund Activity: Q4 2016 in Review

157 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in ANI Pharmaceuticals (ANIP) for Q4 2016, worth a combined $379M — down 4.9% from $399M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of ANIP and 15 opened new positions — a net loss of 10 holders — while 47 trimmed existing stakes and 58 added.

The largest buyer was Perceptive Advisors, adding an estimated $15.6M. The largest seller was Consonance Capital Management, cutting an estimated $9.88M.

  • 157 institutional investors held ANI Pharmaceuticals (ANIP) as of Q4 2016, down from 170 in Q3 2016.
  • Funds reported $379M of ANI Pharmaceuticals stock for Q4 2016, down 4.9% quarter-over-quarter.
  • 15 funds opened new ANI Pharmaceuticals positions in Q4 2016 and 25 closed out, a net change of -10 holders.
  • The largest ANI Pharmaceuticals buyer in Q4 2016 was Perceptive Advisors, an estimated $15.6M added.
  • The largest ANI Pharmaceuticals seller in Q4 2016 was Consonance Capital Management, an estimated $9.88M sold.

Based on aggregated 13F filings for Q4 2016.